Detalhe da pesquisa
1.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
2.
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Rheumatology (Oxford)
; 60(1): 380-391, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929463
3.
Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
Clin Exp Rheumatol
; 38(1): 122-128, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498068
4.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396903
5.
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
JAMA
; 321(5): 461-472, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721294
6.
Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
Ann Rheum Dis
; 77(2): 281-288, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29097373
7.
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
Ann Rheum Dis
; 76(10): 1707-1715, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28611080
8.
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Ann Rheum Dis
; 76(8): 1426-1431, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473425
9.
Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
Respir Res
; 18(1): 141, 2017 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720095
10.
Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
Clin Exp Rheumatol
; 40(1): 198, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088690
11.
The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review.
Rheumatol Int
; 37(2): 179-187, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803965
12.
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Ann Rheum Dis
; 79(6): 846-848, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111583
13.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573653
14.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674476
15.
A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
Ann Rheum Dis
; 74(5): 867-75, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24412895
16.
Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Rheumatology (Oxford)
; 54(12): 2156-65, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26175471
17.
Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis.
Pharmacogenet Genomics
; 24(8): 401-5, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24978393
18.
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Ann Rheum Dis
; 73(4): 654-61, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23434570
19.
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.
Rheumatology (Oxford)
; 53(11): 2100-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24939677
20.
Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) Database.
Acta Oncol
; 53(9): 1245-50, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24913152